Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Thrombocytopenia × lusutrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 1

Interventions

eltrombopag 7 romiplostim 6 Cytarabine 3 Carboplatin 3 Platelet Transfusion 2 Cyclophosphamide 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sodium thiosulfate 1 pegfilgrastim 1 oprelvekin 1 ofatumumab 1 lusutrombopag 1 fludarabine 1 etoposide phosphate 1 avatrombopag 1 Stem Cell Transplantation 1 Sirolimus 1 Rituximab 1 Microarray Analysis 1 Lenalidomide 1 Interleukin-11 1 Ifosfamide 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Gemcitabine 1 Flow Cytometry 1 Filgrastim 1 Etoposide 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389621 2018-10-30

L-PLUS 2

Shionogi Inc.

Phase 3 Completed

215 enrolled 24 charts 1 FDA

Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡